Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Liraglutide, an agonist of the glucagon-like peptide-1 (GLP-1) receptor, likewise demonstrated strong neuroprotective effects in animal models of Parkinson's disease
FDA Approves Lillys ZepboundTM (Tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems, November 8, 2023
But with the popularity of Ozempic and Mounjaro exploding, some have started mass producing replica versions of the drugs something regulators were totally unprepared for
Payer: Enhanced persistence and reduced complications over time could mean downstream cost savings
Tirzepatide was approved as Mounjaro in 2022 and as Zepbound in 2023
US$ 27.72
US$ 22.34
US$ 24.19
US$ 23.84
US$ 26.51
US$ 22.31
US$ 23.18
US$ 27.50
US$ 24.32
US$ 29.30
US$ 27.69
US$ 28.27
US$ 20.93
US$ 26.93
US$ 27.95
